Korean Market
EXCH
UNION KOREA PHARM
★

Change of Largest Shareholder to Bukwang Pharmaceutical via Third-Party Allotment under Rehabilitation Plan… Existing Shareholders Diluted by 75%, Short-Term Stock Pressure Expected

 
EXCH
UNION KOREA PHARM
★★★★

Massive third-party allocation capital increase for rehabilitation... risk of 88% dilution for existing shareholders

 
OWNR
UNION KOREA PHARM
★★★★

Park Kwang-seok Acquires 9,455,845 Shares at 500 Won via Debt-to-Equity Swap Under Rehabilitation Plan, Stake at 15.87%: Massive Dilution Threatens Shareholder Value

 
OWNR
UNION KOREA PHARM
★★★★

Park Kwang-seok Acquires 9,455,845 Shares via Debt-to-Equity Swap... Total Shares Surge 7.5-Fold, Severely Diluting Existing Shareholders

 
EXCH
UNION KOREA PHARM
★★★★

UNION KOREA PHARM Extends Trading Suspension Period Due to Capital Reduction and Delisting Risk

 
EXCH
UNION KOREA PHARM
★★★★★

Failure to Complete Change Listing After Capital Reduction Triggers Immediate Delisting Risk

 
EXCH
UNION KOREA PHARM
★

Debt-to-Equity Swap Capital Increase of 25.8 Billion Won Under Rehabilitation Plan

 
EXCH
UNION KOREA PHARM
★★★

Change of Largest Shareholder via Debt-to-Equity Swap Under Rehabilitation (Stake from 19.93% to 15.87%)

 
MATR
UNION KOREA PHARM
★★★

Decision on Rights Offering via Debt-to-Equity Swap Following Rehabilitation Plan Approval (Debt Repayment Purpose, Expected Change of Largest Shareholder)

 
MATR
UNION KOREA PHARM
★★★

Decision on Third-Party Allotment Capital Increase under Rehabilitation Plan (Change of Largest Shareholder Expected)

 
MATR
UNION KOREA PHARM
★★★

Capital Reduction Following Rehabilitation Plan Approval

 
PERI
UNION KOREA PHARM
★★★★★

Rehabilitation Proceedings and Delisting Risk, Severely Deteriorated Financial Structure

 
EXCH
UNION KOREA PHARM
★★

Rehabilitation Plan Approved – Massive Dilution via Debt-to-Equity and Rights Offering